Prescription drug · ANDA
Irbesartan NDC 31722-161
Irbesartan 150 mg/1 · Tablet · Oral · Camber Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 31722-161-10 | 3172201611031722016110 | 1000 TABLET in 1 BOTTLE (31722-161-10)Marketed from Oct 6, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Irbesartan
- Generic name (nonproprietary)
- irbesartan
- Active ingredients
- Irbesartan — 150 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Camber Pharmaceuticals, Inc.NDC labeler code 31722
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204774
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 31722-161_0f3408b4-44be-4a92-a59f-9b5a9716bc9aSPL ID 0f3408b4-44be-4a92-a59f-9b5a9716bc9aSPL set ID 0f3408b4-44be-4a92-a59f-9b5a9716bc9aRxCUI 200094, 200095, 200096UNII J0E2756Z7NUPC 0331722162050, 0331722161107
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N431722016110followed by a unit qualifier and the quantityPackage 31722-0161-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Irbesartan is an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 ) 1.1 Hypertension Irbesartan is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihyp…
Excerpt only. Read the full label for complete information.
About NDC 31722-161
- What is NDC 31722-161?
- 31722-161 is the product NDC for Irbesartan, Irbesartan 150 mg/1 tablet, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Irbesartan.
- What is the active ingredient?
- Irbesartan.
- Who is the labeler?
- Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Irbesartan?
- 77 other product NDCs are listed under this name. See all Irbesartan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Irbesartan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Irbesartan | Irbesartan 75 mg/1 | TabletOral | NorthStar RxLLC | 72603-670 | 72603-0670-01 |
| Irbesartan | Irbesartan 150 mg/1 | TabletOral | NorthStar RxLLC | 72603-671 | 72603-0671-01 |
| Irbesartan | Irbesartan 300 mg/1 | TabletOral | NorthStar RxLLC | 72603-672 | 72603-0672-0172603-0672-02 |
| Irbesartan | Irbesartan 75 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-327 | 72205-0327-0572205-0327-0672205-0327-30+2 more |
| Irbesartan | Irbesartan 150 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-328 | 72205-0328-0572205-0328-0672205-0328-10+3 more |
| Irbesartan | Irbesartan 300 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-329 | 72205-0329-0572205-0329-0672205-0329-30+2 more |
| Irbesartan | Irbesartan 75 mg/1 | TabletOral | AvKARE | 42291-940 | 42291-0940-90 |
| Irbesartan | Irbesartan 150 mg/1 | TabletOral | AvKARE | 42291-941 | 42291-0941-90 |
| Irbesartan | Irbesartan 300 mg/1 | TabletOral | AvKARE | 42291-942 | 42291-0942-90 |
| Irbesartan | Irbesartan 150 mg/1 | TabletOral | Quality Care Products, LLC | 83008-084 | 83008-0084-30 |
Other NDCs under ANDA 204774
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Irbesartan | Irbesartan 75 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-160 |
| Irbesartan | Irbesartan 300 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-162 |
| Irbesartan | Irbesartan 75 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-160 |
| Irbesartan | Irbesartan 150 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-161 |
| Irbesartan | Irbesartan 300 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-162 |